{"organizations": [], "uuid": "fe312485f315eb33bf10687b37d78a56b70225a1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180108.html", "section_title": "Archive News &amp; Video for Monday, 08 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-natus-medical-announces-2018-annua/brief-natus-medical-announces-2018-annual-and-first-quarter-financial-guidance-idUSASB0C00R", "country": "US", "domain_rank": 408, "title": "BRIEF-Natus Medical Announces 2018 Annual And First Quarter Financial Guidance", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.148, "site_type": "news", "published": "2018-01-08T19:56:00.000+02:00", "replies_count": 0, "uuid": "fe312485f315eb33bf10687b37d78a56b70225a1"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-natus-medical-announces-2018-annua/brief-natus-medical-announces-2018-annual-and-first-quarter-financial-guidance-idUSASB0C00R", "ord_in_thread": 0, "title": "BRIEF-Natus Medical Announces 2018 Annual And First Quarter Financial Guidance", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "otometrics", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 8 (Reuters) - Natus Medical:\n* REVENUE IN Q4 WAS LOWER THAN EXPECTED DUE TO WEAKNESS IN OUR U.S. NEURODIAGNOSTIC BUSINESS\n* ‍FULL YEAR AND Q1 2018 NON-GAAP GUIDANCE DOES NOT INCLUDE EXPENSES FOR U.S. MEDICAL DEVICE TAX​\n* DUE IN PART TO DISRUPTION FROM INTEGRATION OF COMPUTER SYSTEMS, Q4 REVENUE ALSO LOWER THAN EXPECTED AT OTOMETRICS\n* ‍IF NOT REPEALED OR SUSPENDED, MEDICAL DEVICE TAX WILL HAVE AN ANNUAL AFTER TAX COST OF APPROXIMATELY $3.0 MILLION​\n* INCREASING INVESTMENTS IN KEY PRODUCT AREAS IN 2018 * ANNOUNCES 2018 ANNUAL AND FIRST QUARTER FINANCIAL GUIDANCE\n* SEES FY 2018 NON-GAAP EARNINGS PER SHARE $1.60 TO $1.65 * SEES Q1 2018 REVENUE $125 MILLION TO $127 MILLION * SEES FY 2017 REVENUE $500.5 MILLION TO $501.5 MILLION * SEES FY 2018 REVENUE $535 MILLION TO $540 MILLION * SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.23 TO $0.24 * SEES Q4 2017 REVENUE ABOUT $131 MILLION TO $132 MILLION * EXPECT OTOSCAN REVENUES TO RAMP IN SECOND HALF OF 2018 Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-08T19:56:00.000+02:00", "crawled": "2018-01-09T17:09:36.003+02:00", "highlightTitle": ""}